We've identified one, single group of stocks that have outperformed everything else in the markets – by a huge margin – over more than a decade.
| |
Dear Reader, This is exactly what you read Stansberry Research for. We've identified one, single group of stocks that have outperformed everything else in the markets – by a huge margin – over more than a decade. During that time, they've returned an astonishing 56% per year, on average. That means: 11x more than gold... More than 4x more than the NASDAQ Biotech ETF... And nearly DOUBLE the famous FAANG stocks... Yet they're still in the "early innings" of a decades-long trend. Just to be clear, I'm talking about a specific group in a specific sector. (This isn't some tricky metaphor... and it has nothing to do with portfolios.) In this presentation, I name the exact group, which you can easily locate and invest in on your own – if you choose to do so – without spending a single penny. We're not "holding back" the critical details... I highly recommend you get the name of this group – and find out why it's nearly perfect for one of our No. 1 favorite stock strategies – while this presentation is still online. Regards, Brett Aitken
Publisher, Stansberry Research P.S. The best opportunities in this group could easily return 1,000% or more going forward. And they're very well positioned to benefit from the current market Melt-Up. So you'll need to move quickly to see the biggest gains. Get the full story right here. |
|
|
All contents of this e-mail are copyright 2020 by Stansberry Research. All rights reserved. Reproducing any part of this document is prohibited without the express written consent of Porter Stansberry. Protected by U.S. Copyright Law {Title 17 U.S.C. Section 101 et seq., Title 18 U.S.C. Section 2319}: Infringements can be punishable by up to five years in prison and $250,000 in fines.
DISCLAIMER: The work included in this publication is based on SEC filings, current events, interviews, and corporate press releases. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility. The views expressed in this publication do not necessarily reflect the views of Stansberry Research.
You're receiving this email at [email protected]. If you have any questions about your subscription, or would like to change your email settings, please contact Stansberry Research at (888) 261-2693 Monday-Friday between 9:00 a.m. and 5:00 p.m. Eastern Time. Or if calling internationally, please call 443-839-0986. Stansberry Research, 1125 N Charles Street Baltimore, MD 21201. If you wish to contact us by email, please do not reply to this message but instead go to [email protected].
To unsubscribe from this mailing, click here: Unsubscribe
|
|
|
